P

Inventor

XU YIYANG

US19 patents
⚠️ This page may combine multiple inventors who share the name “XU YIYANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

EUREKA THERAPEUTICS INC

13 patents
US10822389B2Nov 3, 2020

Antibody/T-cell receptor chimeric constructs and uses thereof

EUREKA THERAPEUTICS INC11 citations93
US10464988B2Nov 5, 2019

Antibody/T-cell receptor chimeric constructs and uses thereof

EUREKA THERAPEUTICS INC16 citations93
US10098951B2Oct 16, 2018

Antibody/T-cell receptor chimeric constructs and uses thereof

EUREKA THERAPEUTICS INC17 citations93
US10011658B2Jul 3, 2018

Constructs targeting AFP peptide/MHC complexes and uses thereof

EUREKA THERAPEUTICS INC14 citations83
US10822413B2Nov 3, 2020

Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof

EUREKA THERAPEUTICS INC13 citations81
US11613573B2Mar 28, 2023

Chimeric antibody/T-cell receptor constructs and uses thereof

EUREKA THERAPEUTICS INC1 citations71
US11421013B2Aug 23, 2022

Antibody/T-cell receptor chimeric constructs and uses thereof

EUREKA THERAPEUTICS INC3 citations71
US11976105B2May 7, 2024

Antibody/T-cell receptor chimeric constructs and uses thereof

EUREKA THERAPEUTICS INC0 citations61
US12479924B2Nov 25, 2025

Constructs specifically recognizing Glypican 3 and uses thereof

EUREKA THERAPEUTICS INC0 citations58
US11965021B2Apr 23, 2024

Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof

EUREKA THERAPEUTICS INC0 citations58
US11447564B2Sep 20, 2022

Constructs specifically recognizing glypican 3 and uses thereof

EUREKA THERAPEUTICS INC1 citations58
US11827672B2Nov 28, 2023

Constructs trageting CD22 and uses thereof

EUREKA THERAPEUTICS INC0 citations57
US11274157B2Mar 15, 2022

Constructs targeting histone H3 peptide/MHC complexes and uses thereof

EUREKA THERAPEUTICS INC0 citations50

WISCONSIN ALUMNI RES FOUND

3 patents

MEMORIAL SLOAN KETTERING CANCER CENTER

2 patents

FIVE PRIME THERAPEUTICS INC

1 patent